Who We Are

Get to Know KORU

KORU is, first and foremost, a patient-centric organization that will go the extra mile for our customers, providers, and partners who depend on our devices. We are a world-class manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).


Our Company Shared Values

Customer First

Customers are at the center of everything we do.

We Are One KORU

We desire to foster an engaging and inclusive workspace and recognize that we are the sum of our collective talent.

We Embrace Challenges

We are transformational in our thinking, questioning the limits of what is possible by asking “why not,” “why not now” and “why not bigger?” We value employees with the grit and willingness to do whatever it takes to figure it out and make it work.

We Compete to Win

We find ways to overcome competition. It challenges us to innovate and drive value in our business.

We Have Fun and Celebrate

We will celebrate our wins/success together.

Who We Serve

Patients: We are a patient-centric organization through and through. We are focused on offering unparalleled subcutaneous infusion devices to deliver life-saving treatments to our patient community. In addition to enhancing patient experiences and providing them the freedom to infuse where and when they choose, we strive to involve ourselves within the patient community by providing resources, education, and support.

Patient Advocates: Patient advocates play a vital role in the PIDD and CIDP communities. Whether we are working with specialty pharmacists, nurses, doctors, or homecare providers, we strive to provide them the support and resources they need to serve as patient advocates.

Specialty Pharmacies: We work hard to establish long term relationships with specialty pharmacies and strive to be their trusted partners. We know specialty pharmacists seek safe and efficient medical devices for patients and we are committed to providing them with these products and the associated resources they require.

Distributors: Distributors play an integral role in getting patients the care they need. At KORU, we work closely with our distributors and ensure that we provide adequate educational materials, resources, and information to allow them to sell our products effectively.

Clinicians, Doctors & Nurses: Doctors and nurses play a vital role in the primary immunodeficiency and Chronic Inflammatory Demyelinating Polyneuropathy communities. We know how important it is for them to provide excellent patient care and therapeutic options to their patients. With this in mind, we are committed to offering an unparalleled infusion system and the associated educational resources for doctors and nurses to provide to their patients.

Investors: At KORU, we are dedicated to being a financially stable, accountable organization and have a commitment to transparent communication with each of our stakeholders. Investor relations is key to our success as an organization and at the forefront of each decision we make.

Home Infusion Made Simple

KORU has been amazing, as soon as I posted anything on social media with their pump, they reached out to me to see if there was anything I needed. It made me feel important and taken care of.

- KORU Patient

My experiences with KORU have been great. It seems like such a close-knit company since they are able to interact and engage with individual patients via social media channels, which isn’t always the case with big medical organizations. I know if I ever had an issue and needed to contact, KORU would help me to the best of their ability.

- KORU Patient

Our Story

KORU Medical Systems is a leading developer and manufacturer of medical devices and supplies. We focus on home and specialty infusion solutions, emphasizing responsive problem-solving for our customers with careful consideration to the patient experience. The company was incorporated in March 1980 and is now publicly traded on the NASDAQ Capital Market (NASDAQ: KRMD). We are located in Mahwah, NJ (USA), located approximately 30 miles northwest of New York City.

Our primary products include the Freedom Integrated Infusion System: the FREEDOM60® and FreedomEdge® Syringe Drivers, Precision Flow Rate Tubing™, and HIgH-Flo Subcutaneous Safety Needle Sets™

Worldwide, KORU Medical Systems drives healthcare inspiration – in the minds of our patients, our employees, our customers, and our shareholders – to give everyone greater freedom for living. Our products and customer service support are offered throughout the world through a global network of distributors and service providers. We design and manufacture safe, affordable medical devices to make quality healthcare a reality for everyone.

We are excited to expand into new markets with innovative, technical products. We look forward to productive partnerships with people and companies who share our vision and can help us effectively deliver our value promise to stakeholders in our industry.

Our Executive Team

Chief Executive Officer and President, Director since 2022

Linda Tharby

Chief Executive Officer and President, Director since 2022

Ms. Tharby has served as the Company’s Chief Executive Officer since April 2021. Ms. Tharby has over 25 years of executive leadership experience building and leading strong performing global organizations that develop and commercialize products and service innovations, while delivering solutions to patients in the home setting. Prior to joining the Company, Ms. Tharby spent the last 24 years working in various roles of increased responsibility at Becton Dickinson (“BD”). Ms. Tharby was a member of the Executive Leadership team of BD that transformed the company from an $8 billion medical supplies company to an $18 billion global medical technology company. Ms. Tharby’s most recent role at BD was Chief Customer Experience Officer from July 2018 through December 2020. In her prior role, as BD’s Chief Human Resources Officer, from October 2016 through July 2018, she led the company through its $24 billion acquisition and integration of C.R. Bard in 2017. She also held numerous global business leadership roles at BD, including Executive Vice President and President of Life Sciences, Group President of Pre-Analytical Systems and Biosciences, Worldwide President of Diabetes Care, and Vice President/General Manager of Pharmaceutical Systems. Ms. Tharby has an Honors Bachelor of Business Administration from Wilfrid Laurier University in Waterloo, Ontario Canada.

Chief Financial Officer

Tom Adams

Chief Financial Officer

Tom joins KORU with medical device industry experience, coming from Integra Life Sciences, where he spent the last 10 years, with his most recent role there as Senior Director of Finance (FP&A).  Previous roles included Group Controller/Head of FP&A and Director of Finance (FP&A). Career highlights include establishing the Finance function for a newly created manufacturing division at Integra, which involved creating processes, setting up systems for reporting, management presentations and hiring a strong team. Tom recently led the financial analysis and negotiation to move Integra’s headquarters to Princeton, NJ, which this deal was recently awarded NJ’s 2019 office real estate deal of the year! He earned his Bachelor of Science in Business Administration-Accounting & Finance from Ohio State University. Tom brings extensive expertise and experience in building forecasts, budgets, modeling, and cost accounting that will support decision making and actions to help drive KORU’s growth.

Chief Technology Officer

Brian Case

Chief Technology Officer

Brian joins the KORU Medical Systems team with over 20 years of research and development experience. Most recently, he spent over 16 years at Fresenius Kabi, a global healthcare company specializing in lifesaving medicines and technologies, as Vice President, Research and Development. Mr. Case provided business and technical leadership for the Transfusion and Cell Technologies division to drive long-term product vitality and competitive advantage of the business and promote entry into new business areas. Prior to Fresenius Kabi, Mr. Case spent six years at Cook Medical, a medical device company, as R&D Program Manager, Advanced Research. While there, he managed a cross-functional team that developed and assessed new technologies to create a product portfolio to service the peripheral disease market. Mr. Case received his Master of Science in Engineering Management from the Rose-Hulman Institute of Technology, and his Bachelor of Science in Engineering Mechanics, from the University of Illinois. In addition, Mr. Case is an inventor on over 100 patents, a Licensed Professional Mechanical Engineer, and a Certified Project Management Professional.
Senior Vice President, Operations

Chris Pazdan

Senior Vice President, Operations

Chris joins the KORU team from Hillrom where he worked as the Vice President of Quality Assurance. In that role he was responsible for all quality functions for Hillrom’s largest manufacturing division. Prior to that role, Chris was the Vice President of QA/RA where he was responsible for enterprise-wide Design Assurance, Supplier Quality Assurance, Project Management Office, and Software. Chris’ proudest professional accomplishments include working with, leading, and helping build great teams. In addition to these efforts, he enjoys making a difference in the healthcare space and improving outcomes for patients and customers.

Chris received his bachelor’s degree in general engineering from the University of Illinois at Urbana-Champaign. He is a ASQ Certified Six Sigma Black Belt, ASQ Certified Quality Engineer and an ASQ Certified Quality Auditor.

Vice President and General Manager of Novel Therapies & International

Josh Bennett

Vice President and General Manager of Novel Therapies & International

Mr. Bennett’s experience spans healthcare product categories, care settings, and end markets, including medical devices / technology, pharmaceuticals, biologics, acute care, and home care. He has been responsible for growth in both U.S. and international markets.

He joins KORU Medical from Salter Labs, a global anesthesia and respiratory medical device manufacturer, where he served as Vice President Sales, Marketing, and Business Development beginning in 2012. Salter Labs merged with SunMed in 2019. Prior to this, he was with Baxter Healthcare, a Fortune 500 diversified global pharmaceutical and device manufacturer. At Baxter he focused on pharmaceuticals and biologics, with an emphasis on product and market development addressing nutrition, hydration, and hemophilia. Mr. Bennett began his career at PwC Consulting (now IBM Global Business Services).

Mr. Bennett received his MBA from the Kellogg School of Management at Northwestern University, where he was a Siebel Scholar and recipient of the Richard M. Clewett Award, and his BBA from Northwood University.

Vice President of Sales

Rob Cannon

Vice President of Sales

Rob brings 30+ years of experience in sales across the healthcare industry with direct experience in home care, specialty pharmacy and with Plasma/Biologics.  Most recently, he served as the Vice President of Strategic Accounts for McKesson Alternate Pharmacy Solutions, where he led the strategy, planning, and implementation of effective sales and marketing strategies focused on the specialty pharma channel. Prior to that role, Rob was the Vice President of Sales for McKesson Plasma and Biologics, where he established and managed a sales team, and as the Senior Director for McKesson Alternate Site Pharmacy, where he spearheaded the development and execution of strategic programs enhancing pharmacy partnerships while also driving value and efficiency. Rob received his Bachelor of Science degree in chemistry from Fordham University. 

Vice President of Medical Affairs

Brent Rutland

Vice President of Medical Affairs

Brent joins KORU with more than 25 years of experience in Medical Affairs.  Prior to joining KORU, Brent was with Baxter Healthcare as a Senior Medical Science Liaison and most recently with La Jolla Pharmaceutical Company as a Senior Director, Health Outcomes. During his tenure he has helped launch 7 vaccines, 4 drugs and 1 device.  Most notably, Brent aided Baxter in the launch of Hylenex for Pediatric SQ rehydration where he also helped build the Medical Affairs department.  Brent has received several awards throughout his career, with the most recent being the President’s Circle Award for Medical Affairs at La Jolla.  Brent holds a Bachelor of Science degree from Texas A&M University, an MBA in Global Management from the University of Houston and his Master of Public Health from the University of North Carolina in Epidemiology.  


We are always looking for dedicated, hard-working team members. If you have the skills and are seeking a challenging growth opportunity, please view our job postings below.

All Positions Offer Opportunity for Advancement

KORU offers a competitive salary and benefits package, including medical, dental, LTD and 401(k).

Current Openings